Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28363604 | 0.80 | DPP4 (0.50) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL27801493 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL11576917 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL31402004 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL157180 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL71958 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL159420 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL30559595 | 0.80 | CYP2D6 (0.56) | CYP2D6SRCDPP4F2LMNA | |
| Phenylglycine SCHEMBL2003211 | 0.78 | CYP2D6 (0.54) | CYP2D6SRCDPP4F2LMNA | |
| SCHEMBL544671 | 0.78 | EPHX1 (0.50) | CYP2D6SRCDPP4F2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60248663-A | — | — | None | — | — | JP | disclosed |
| JP-6220016-A | — | — | None | — | — | JP | disclosed |
| EP-2986625-B1 | MIXED MODE LIGANDS | BIO RAD LABORATORIES (US) | 2020-03-11 | — | — | EP | disclosed |
| US-10583429-B2 | Mixed mode ligands | BIO-RAD LABORATORIES, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| CN-105579463-B | Mixed mode ligands | 生物辐射实验室股份有限公司 | 2020-01-31 | — | — | CN | disclosed |
| EP-2986625-A2 | MIXED MODE LIGANDS | Bio-rad Laboratories, Inc. (US) | 2016-02-24 | — | — | EP | disclosed |
| WO-2015138928-A2 | MIXED MODE LIGANDS | BIO-RAD LABORATORIES, INC. (US) | 2015-09-17 | — | — | WO | disclosed |
| US-20150258539-A1 | MIXED MODE LIGANDS | BIO RAD LABORATORIES (US) | 2015-09-17 | — | — | US | disclosed |
| US-5527824-A | ADMINISTERING IN THE TREATMENT OF ASTHMA, PSORIASIS AND ALLERGIC CONDITIONS | RIKER LABORATORIES, INC. (US) | 1996-06-18 | — | — | US | disclosed |
| US-5498745-A | ANTIALLERGEN INTERMEDIATES, INHIBITORS OF LEUKOTRIENES, LIPOXYGENASE INHIBITORS | RIKER LABORATORIES, INC. (US) | 1996-03-12 | — | — | US | disclosed |
| JP-H06220016-A | SUBSTITUTED PHENYLTHIOACETIC ACID | SUMITOMO CHEM CO LTD | 1994-08-09 | — | — | JP | disclosed |
| US-5237070-A | Antiallergens, inhibiting bronchoconstriction | RIKER LABORATORIES, INC. (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0212848-B1 | SUBSTITUTED-DI-T-BUTYLPHENOLS | RIKER LABORATORIES, INC. (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4801408-A | 3-AMINO-4-FLUORO-6-HALOPHENYLTHIOACETIC ACIDS, 5-SUBSTITUTED ACETANILIDES, HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-01-31 | — | — | US | disclosed |
| EP-0126419-B1 | 2-SUBSTITUTED PHENYL-4,5,6,7-TETRAHYDRO-2H-ISOINDOLE-1,3-DIONES, AND THEIR PRODUCTION AND USE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-08-17 | — | — | EP | disclosed |
| US-4709049-A | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-11-24 | — | — | US | disclosed |
| US-4684397-A | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-08-04 | — | — | US | disclosed |
| EP-0212848-A2 | Substituted-di-t-butylphenols | RIKER LABORATORIES, INC. (US) | 1987-03-04 | — | — | EP | disclosed |
| JP-S60248663-A | AMINOPHENYLTHIOACETIC ACID COMPOUND AND ITS PREPARATION | SUMITOMO CHEM CO LTD | 1985-12-09 | — | — | JP | disclosed |
| EP-0126419-A1 | 2-Substituted phenyl-4,5,6,7-tetrahydro-2H-isoindole-1,3-diones, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150258539-A1 | MIXED MODE LIGANDS | MRPL21, FABP2, MYOF | CYP2D6 4492/4885SRC 2922/4885DPP4 2961/4885 |
| US-10583429-B2 | Mixed mode ligands | MRPL21, CD2BP2, FABP1 | CYP2D6 4395/4885SRC 2138/4885DPP4 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.